0001450708
2015-11-01
2016-07-31
0001450708
2016-07-31
0001450708
us-gaap:CorporateJointVentureMember
aurm:CenturyConcessionMember
2015-11-01
2016-07-31
0001450708
us-gaap:PrincipalOwnerMember
2016-07-31
0001450708
us-gaap:CorporateJointVentureMember
aurm:CenturyConcessionMember
2010-12-31
0001450708
us-gaap:PrincipalOwnerMember
2009-07-31
0001450708
aurm:AxisConsultantsPtyLtdMember
2015-11-01
2016-07-31
0001450708
aurm:AxisConsultantsPtyLtdMember
2016-07-31
0001450708
country:US
2016-07-31
0001450708
us-gaap:CommonStockMember
aurm:FounderMember
us-gaap:PrivatePlacementMember
2008-09-01
2008-09-30
0001450708
us-gaap:CommonStockMember
aurm:PublicOfferingMember
2009-03-01
2009-03-31
0001450708
us-gaap:CommonStockMember
2015-11-01
2016-07-31
0001450708
us-gaap:CommonStockMember
2016-07-31
0001450708
us-gaap:AdditionalPaidInCapitalMember
2015-11-01
2016-07-31
0001450708
us-gaap:AdditionalPaidInCapitalMember
2016-07-31
0001450708
us-gaap:RetainedEarningsMember
2015-11-01
2016-07-31
0001450708
us-gaap:RetainedEarningsMember
2016-07-31
0001450708
us-gaap:SubsequentEventMember
aurm:MedicalTechnologyBusinessMember
us-gaap:ScenarioForecastMember
us-gaap:MaximumMember
2017-07-18
2017-07-19
0001450708
us-gaap:SubsequentEventMember
aurm:MedicalTechnologyBusinessMember
us-gaap:ScenarioForecastMember
2017-07-18
2017-07-19
0001450708
aurm:HumavoxMember
2016-06-27
0001450708
aurm:HumavoxMember
aurm:WarrantsAndOptionsMember
2016-06-27
0001450708
aurm:HumavoxMember
2016-06-01
2016-06-27
0001450708
us-gaap:SubsequentEventMember
aurm:MedicalTechnologyBusinessMember
us-gaap:ScenarioForecastMember
2017-07-19
0001450708
us-gaap:SubsequentEventMember
us-gaap:CommonStockMember
2017-07-01
2017-07-31
0001450708
aurm:HumavoxMember
aurm:FirstInstallmentAmountMember
2016-06-01
2016-06-27
0001450708
aurm:HumavoxMember
2016-07-01
2016-07-31
0001450708
2015-10-31
0001450708
us-gaap:CommonStockMember
2015-10-31
0001450708
us-gaap:AdditionalPaidInCapitalMember
2015-10-31
0001450708
us-gaap:RetainedEarningsMember
2015-10-31
0001450708
aurm:ManagerOfLaosOperationsMember
2015-10-31
0001450708
aurm:AxisConsultantsPtyLtdMember
2015-10-31
0001450708
us-gaap:CommonStockMember
aurm:AxisConsultantsPtyLtdMember
2015-07-01
2015-07-31
0001450708
us-gaap:CommonStockMember
2016-04-02
2016-04-07
0001450708
2017-09-28
0001450708
aurm:PayItSimpleMember
2016-04-01
0001450708
aurm:PayItSimpleMember
aurm:AdditionalEquityMethodInvestmentMember
2016-04-01
0001450708
aurm:PayItSimpleMember
aurm:InterestHoldingPercentageMember
2016-04-01
0001450708
aurm:PayItSimpleMember
2016-04-02
2016-04-30
0001450708
2014-11-01
2015-07-31
0001450708
2016-05-01
2016-07-31
0001450708
2015-05-01
2015-07-31
0001450708
us-gaap:MinimumMember
2014-11-01
2015-10-31
0001450708
us-gaap:MaximumMember
2014-11-01
2015-10-31
0001450708
2014-10-31
0001450708
2015-07-31
0001450708
aurm:ManagerOfLaosOperationsMember
2016-07-31
iso4217:USD
xbrli:shares
iso4217:USD
xbrli:shares
xbrli:pure
10-Q
false
2016-07-31
2016
Q3
AURM
AURUM, INC.
0001450708
--10-31
Smaller Reporting Company
437
197
437
197
276884
205355
276884
205355
1050203
817703
1066827
232500
834327
232500
13585
13560
7833287
7794983
-1326650
13585
7833287
-9173522
-1271985
13560
7794983
-9080528
437
197
0.0001
0.0001
500000000
500000000
135850000
135600000
135850000
135600000
-92994
-92994
1181414
-9906
591987
38329
9000
12000
0.96
1.00
1.00
0.70
0.7286
0.51
96000000
9600000
250000
250000
250000
135850000
135600000
135850000
1327087
1272182
1050203
1066827
-9173522
-9080528
15000000
7500000
0.30
0.10
0.40
38329
38329
5057776
30000000
7500000
100000
100000
2500000
2500000
2500000
0.22
2500000
P24M
0.22
4911
16000000
5500000
2016-07-29
2016-04-06
38329
25
38304
0.7478
0.50
55158
2285000
2028-10-31
2034-10-31
2012
<div style="text-align: center"><table id="z9d3177e54f994c4e8b28e60b2f19ed2b" class="DSPFListTable" cellspacing="0" cellpadding="0" style="width: 100%; font: 10pt Times New Roman, Times, serif"><tr><td style="width: 36pt; vertical-align: top"><div style="text-align: left; font: bold 10pt Times New Roman, Times, serif">(1)</div>
</td>
<td style="width: auto; vertical-align: top">
<div style="text-align: left; font: bold 10pt Times New Roman, Times, serif">ORGANIZATION AND BUSINESS</div>
</td>
</tr>
</table>
</div>
<div style="text-align: left"> </div>
<div style="text-align: justify; text-indent: 36pt; font: 10pt Times New Roman, Times, serif; margin-bottom: 10pt; color: #000000">Aurum, Inc. ("Aurum” or the “Company") is a Delaware corporation originally incorporated in Florida as Liquid Financial Engines, Inc. The principal stockholder of Aurum is Golden Target Pty Ltd., an Australian corporation (“Golden”), which owned 74.78% of Aurum as of July 31, 2016.</div>
<div style="text-align: justify; text-indent: 36pt; font: 10pt Times New Roman, Times, serif; margin-bottom: 10pt; color: #000000">On January 20, 2010, the Company re-incorporated in the state of Delaware (the “Reincorporation”) through a merger involving Liquid Financial Engines, Inc. (“Liquid”) and Aurum, Inc., a Delaware Corporation that was a wholly owned subsidiary of Liquid. The Reincorporation was effected by merging Liquid with Aurum, with Aurum being the surviving entity. For financial reporting purposes Aurum is deemed a successor to Liquid.</div>
<div style="text-align: justify; text-indent: 36pt; font: 10pt Times New Roman, Times, serif; margin-bottom: 10pt; color: #000000">In July 2009, Golden acquired a 96% interest in Aurum from certain stockholders. In connection therewith, the Company appointed a new President/Chief Executive Officer and Chief Financial Officer/Secretary and a new sole Director. The sole director and stockholder of Golden is also the President of the Company.</div>
<div style="text-align: justify; text-indent: 36pt; font: 10pt Times New Roman, Times, serif; margin-bottom: 10pt; color: #000000">Commencing August 2009, the Company decided to focus on mineral exploration for gold and copper in the Lao Peoples Democratic Republic (Lao P.D.R or Laos).</div>
<div style="text-align: justify; text-indent: 36pt; font: 10pt Times New Roman, Times, serif; margin-bottom: 10pt; color: #000000">In December 2010, the Company executed a Management and Shareholders Agreement with Argonaut Overseas Investments Ltd (“AOI”), an indirectly wholly owned Subsidiary of Argonaut Resources N.L., in respect to Argonaut’s 70% held Century Concession in Laos.</div>
<div style="text-align: justify; text-indent: 36pt; font: 10pt Times New Roman, Times, serif; margin-bottom: 10pt; color: #000000">The agreement appointed Aurum as the manager of the Century Thrust Joint Venture Agreement (“Joint Venture”) and gave the Company the right to earn 72.86% of AOI’s interest in the Joint Venture which is equivalent to a 51% beneficial interest in the Century Concession.</div>
<div style="text-align: justify; text-indent: 36pt; font: 10pt Times New Roman, Times, serif; margin-bottom: 10pt; color: #000000">The Century Concession expired in fiscal 2014 and was not renewed. As a result, the Company no longer has any exploration interests in Laos.</div>
<div style="text-align: justify; text-indent: 36pt; font: 10pt Times New Roman, Times, serif; margin-bottom: 10pt; color: #000000">On April 1, 2016 the Company announced that it had entered into an agreement with an Israeli company, PayItSimple Ltd and its subsidiaries (PayItSimple) whereby the Company would invest $15 million directly into PayItSimple by September 5, 2016 to acquire a 30% interest in PayItSimple, and a further $7.5 million into PayItSimple over 18 months to acquire a further 10% interest in PayItSimple, taking its holding to 40% of interest in PayItSimple.  PayItSimple owns a business known as Splitit. On April 6, 2016 the Company terminated the proposed acquisition of PayItSimple.</div>
<div style="text-align: justify; text-indent: 36pt; font: 10pt Times New Roman, Times, serif; margin-bottom: 10pt; color: #000000">On June 27, 2016 the Company announced that it had entered into a binding term sheet with the shareholders of Israeli company, Humavox Ltd (Humavox), a company that creates wireless charging solutions. In accordance with the proposed acquisition of Humavox, Aurum would acquire 100% of the shares of Humavox and 100% of the warrants and options to acquire shares of Humavox in exchange for the issue of shares of common stock of Aurum representing 50% of the shares of common stock of Aurum post issue on a fully-diluted basis, including the investment of an amount of US$16 million in Humavox.  The investment would take place in unconditional instalments over a period of 24 months following the closing. The closing of the merger was subject to certain closing conditions, including the investment in Humavox of the first instalment of the investment in the amount of $5.5 million. On July 29, 2016 the Company terminated the proposed acquisition of Humavox.</div>
<div style="text-align: left; text-indent: 36pt; font: 10pt Times New Roman, Times, serif; margin-bottom: 10pt">On July 19, 2017, the Company entered into a Term Sheet with Lior Wayn, Erez Glazer and Dr Guy Shalom, (collectively, the ‘’Sellers”)  for the acquisition of all of the issued shares of a medical technology business. The Company has a 120 day period to conduct due diligence and negotiate a formal share sale agreement.</div>
<div style="text-align: left; text-indent: 36pt; font: 10pt Times New Roman, Times, serif; margin-bottom: 10pt">The purchase price is up to USD$7,500,000 which is to be satisfied as follows:</div>
<div style="text-align: center"><br />
</div>
<div style="text-align: center">
<table id="zd5ad5cd58a1342d48270b55ac5d588cb" class="DSPFListTable" cellspacing="0" cellpadding="0" style="width: 100%; font: 10pt Times New Roman, Times, serif">
<tr>
<td style="width: 72pt; vertical-align: top">
<div style="text-align: left; font: 10pt Times New Roman, Times, serif; margin-left: 54pt">a)</div>
</td>
<td style="width: auto; vertical-align: top">
<div style="text-align: justify; font: 10pt Times New Roman, Times, serif">The sum of USD$100,000 payable to the Sellers for due diligence expenses, 30 business days from the execution of the Term Sheet;</div>
</td>
</tr>
</table>
</div>
<div style="text-align: center"><br />
</div>
<div style="text-align: center">
<table id="zbbad0ef89cab4deba4915e53cef9d7b3" class="DSPFListTable" cellspacing="0" cellpadding="0" style="width: 100%; font: 10pt Times New Roman, Times, serif">
<tr>
<td style="width: 72pt; vertical-align: top">
<div style="text-align: left; font: 10pt Times New Roman, Times, serif; margin-left: 54pt">b)</div>
</td>
<td style="width: auto; vertical-align: top">
<div style="text-align: justify; font: 10pt Times New Roman, Times, serif"> A further USD$100,000 each month after the date in a) above for due diligence expenses, for 3 months,  payable to the Sellers for working capital purposes;</div>
</td>
</tr>
</table>
</div>
<div style="text-align: center"><br />
</div>
<div style="text-align: center">
<table id="zfb82f57e14b64b8485a5b91009ec1fb1" class="DSPFListTable" cellspacing="0" cellpadding="0" style="width: 100%; font: 10pt Times New Roman, Times, serif">
<tr>
<td style="width: 72pt; vertical-align: top">
<div style="text-align: left; font: 10pt Times New Roman, Times, serif; margin-left: 54pt">c)</div>
</td>
<td style="width: auto; vertical-align: top">
<div style="text-align: justify; font: 10pt Times New Roman, Times, serif">An issue of fully paid ordinary shares of common stock of the Company to the value of USD$2,500,000 (less any payments made to the Sellers under (a) and (b) above) to the Sellers at an issue price of USD$0.22 per share of common stock (Consideration Shares);</div>
</td>
</tr>
</table>
</div>
<div style="text-align: center"><br />
</div>
<div style="text-align: center">
<table id="z74d17e25311b4e95baa03bed4d9c71ac" class="DSPFListTable" cellspacing="0" cellpadding="0" style="width: 100%; font: 10pt Times New Roman, Times, serif">
<tr>
<td style="width: 72pt; vertical-align: top">
<div style="text-align: left; font: 10pt Times New Roman, Times, serif; margin-left: 54pt">d)</div>
</td>
<td style="width: auto; vertical-align: top">
<div style="text-align: justify; font: 10pt Times New Roman, Times, serif">The issue to the Sellers of shares of common stock to the equivalent to USD$2,500,000 at the issue price of USD$0.22, subject to the Sellers achieving sales revenue of USD$100,000 within twelve months after the first anniversary of Completion; and</div>
</td>
</tr>
</table>
</div>
<div style="text-align: center"><br />
</div>
<div style="text-align: center">
<table id="z97392d276c1c4653b73084c196f98881" class="DSPFListTable" cellspacing="0" cellpadding="0" style="width: 100%; font: 10pt Times New Roman, Times, serif">
<tr>
<td style="width: 72pt; vertical-align: top">
<div style="text-align: left; font: 10pt Times New Roman, Times, serif; margin-left: 54pt">e)</div>
</td>
<td style="width: auto; vertical-align: top">
<div style="text-align: justify; font: 10pt Times New Roman, Times, serif">The issue to the Sellers of shares of common stock to the equivalent to USD$2,500,000 at the issue price of USD$0.22, subject to the Sellers achieving sales revenue of USD$1,000,000 within twelve months after the first anniversary of Completion.</div>
</td>
</tr>
</table>
</div>
<div style="text-align: center"><br />
</div>
<div style="text-align: left; text-indent: 36pt; font: 10pt Times New Roman, Times, serif; color: #000000">If the Transaction is terminated or is in the reasonable opinion of the Company unable to proceed at any point, the Vendors and the Sellers have agreed to convert any monies paid to the Sellers under (a) and (b) above into convertible securities in the Sellers.</div>
<div style="text-align: center"><br />
</div>
<div style="text-align: left; text-indent: 36pt; font: 10pt Times New Roman, Times, serif; color: #000000">As part of the agreement and as a condition to completion, the Company will raise USD$2,500,000.</div>
<div style="text-align: center"><br />
</div>
<div style="text-align: left; text-indent: 36pt; font: 10pt Times New Roman, Times, serif; color: #000000">Pending completion, the Sellers are required to carry on business in the ordinary course.</div>
<div style="text-align: center"><br />
</div>
<div style="text-align: justify; text-indent: 36pt; font: 10pt Times New Roman, Times, serif; margin-bottom: 10pt; color: #000000">The Company’s ability to continue operations for the foreseeable future is dependent upon future funding from affiliated entities, capital raisings, or its ability to commence revenue producing operations and positive cash flows.</div>
<div style="text-align: center"><table id="zd7424f81cb1f4e9a92bcd7993e3fc974" class="DSPFListTable" cellspacing="0" cellpadding="0" style="width: 100%; font: 10pt Times New Roman, Times, serif"><tr><td style="width: 36pt; vertical-align: top"><div style="text-align: left; font: bold 10pt Times New Roman, Times, serif">(2)</div>
</td>
<td style="width: auto; vertical-align: top">
<div style="text-align: left; font: bold 10pt Times New Roman, Times, serif">RECENT ACCOUNTING PRONOUNCEMENTS</div>
</td>
</tr>
</table>
</div>
<div style="text-align: left"> </div>
<div style="text-align: justify; text-indent: 36pt; font: 10pt Times New Roman, Times, serif; margin-bottom: 10pt; color: #000000">The Company has implemented all new accounting pronouncements that are in effect and applicable to the Company. These pronouncements did not have any material impact on the consolidated financial statements unless otherwise disclosed, and the Company does not believe that there are any other new accounting pronouncements that have been issued that might have a material impact on its financial position or results of operations.</div>
<div style="text-align: center"><table id="z6915020c8d3d4a4c951cccbb4b03dfc5" class="DSPFListTable" cellspacing="0" cellpadding="0" style="width: 100%; font: 10pt Times New Roman, Times, serif"><tr><td style="width: 36pt; vertical-align: top"><div style="text-align: left; font: bold 10pt Times New Roman, Times, serif">(3)</div>
</td>
<td style="width: auto; vertical-align: top">
<div style="text-align: left; font: bold 10pt Times New Roman, Times, serif">GOING CONCERN</div>
</td>
</tr>
</table>
</div>
<div style="text-align: left"> </div>
<div style="text-align: justify; text-indent: 36pt; font: 10pt Times New Roman, Times, serif; margin-bottom: 10pt; color: #000000">The accompanying consolidated financial statements have been prepared in conformity with accounting principles generally accepted in the United States of America, which contemplate continuation of Aurum as a going concern. Aurum has incurred net losses since inception and may continue to incur substantial and increasing losses for the next several years, all of which raises substantial doubt as to its ability to continue as a going concern.</div>
<div style="text-align: justify; text-indent: 35.45pt; font: 10pt Times New Roman, Times, serif; margin-bottom: 9pt">In addition, Aurum is reliant on loans and advances from corporations affiliated with the Company. Based on discussions with these affiliate companies, the Company believes this source of funding will continue to be available. Other than the arrangements noted above, the Company has not confirmed any other arrangements for ongoing funding. As a result the Company may be required to raise funds by additional debt or equity offerings in order to meet its cash flow requirements during the forthcoming year. However, there can be no</div>
<div style="text-align: justify; text-indent: 36pt; font: 10pt Times New Roman, Times, serif; margin-bottom: 10pt; color: #000000">The retained deficit of the Company at July 31, 2016 amounted to approximately $9,173,522.</div>
<div style="text-align: center"><table id="za86d7ffcb7ef4809b95222aa3c0b44a7" class="DSPFListTable" cellspacing="0" cellpadding="0" style="width: 100%; font: 10pt Times New Roman, Times, serif"><tr><td style="width: 36pt; vertical-align: top"><div style="text-align: left; font: bold 10pt Times New Roman, Times, serif">(4)</div>
</td>
<td style="width: auto; vertical-align: top">
<div style="text-align: left; font: bold 10pt Times New Roman, Times, serif">AFFILIATE TRANSACTIONS</div>
</td>
</tr>
</table>
</div>
<div style="text-align: left"> </div>
<div style="text-align: justify; text-indent: 36pt; font: 10pt Times New Roman, Times, serif; margin-bottom: 10pt; color: #000000">The Company entered into an agreement with AXIS Consultants Pty Ltd (“AXIS”) to provide management and administration services to the Company. AXIS is affiliated through common management. The Company is one of nine affiliated companies to which AXIS provides services. Each of the companies has some common Directors, officers and shareholders. Currently, there are no material arrangements or planned transactions between the Company and any of the affiliated companies other than AXIS.</div>
<div style="text-align: justify; text-indent: 36pt; font: 10pt Times New Roman, Times, serif; margin-bottom: 10pt">During the nine months ended July 31, 2016, AXIS provided services in accordance with the services agreement, incurred direct costs on behalf of the Company and was repaid $4,911. During the nine months ended July 31, 2016, the foreign exchange effect on the amounts owed to affiliates was a loss of $55,158. The amounts owed to AXIS as of July 31, 2016 and October 31, 2015 is $817,703 and $834,327, respectively. At July 31, 2016, the Company owed the former Managing Director of its Laos operation $232,500 (2015: $232,500). Both amounts are reflected in non-current liabilities - advance from affiliates. During the nine months ended July 31, 2016 and 2015, the affiliates have agreed not to charge interest.</div>
<div style="text-align: justify; text-indent: 36pt; font: 10pt Times New Roman, Times, serif; margin-bottom: 10pt; color: #000000">The Company intends to repay these amounts with funds raised either via additional debt or equity offerings. Both affiliates have agreed not to call the advance within the next twelve months and accordingly the Company has classified the amounts payable as non-current in the accompanying balance sheet.</div>
<div style="text-align: center"><table id="z2c5d8a03f3024c8e9586cb2db9784428" class="DSPFListTable" cellspacing="0" cellpadding="0" style="width: 100%; font: 10pt Times New Roman, Times, serif"><tr><td style="width: 36pt; vertical-align: top"><div style="text-align: left; font: bold 10pt Times New Roman, Times, serif">(5)</div>
</td>
<td style="width: auto; vertical-align: top">
<div style="text-align: left; font: bold 10pt Times New Roman, Times, serif">INCOME TAXES</div>
</td>
</tr>
</table>
</div>
<div style="text-align: left"> </div>
<div style="text-align: justify; text-indent: 36pt; font: 10pt Times New Roman, Times, serif; margin-bottom: 10pt; color: #000000">Aurum files its income tax returns on an accrual basis.</div>
<div style="text-align: justify; text-indent: 36pt; font: 10pt Times New Roman, Times, serif; margin-bottom: 10pt; color: #000000">The Company follows the accounting requirements associated with uncertainty in income taxes using the provisions of FASB ASC 740, Income Taxes. Using that guidance, tax positions initially need to be recognized in the consolidated financial statements when it is more-likely-than-not the positions will be sustained upon examination by the tax authorities. It also provides guidance for de-recognition, classification, interest and penalties, accounting in interim periods, disclosure and transition. As of July 31, 2016, the Company has no uncertain tax positions that qualify for either recognition or disclosure in the consolidated financial statements.</div>
<div style="text-align: justify; text-indent: 36pt; font: 10pt Times New Roman, Times, serif; margin-bottom: 10pt; color: #000000">The Company is required to file tax returns in the United States and a summary of the deferred tax asset at July 31, 2016 is as follows:</div>
<div style="text-align: center">
<table id="zd482b361cebc47b9942488b23677f616" cellspacing="0" cellpadding="0" style="width: 100%; font: 10pt Times New Roman, Times, serif">
<tr>
<td style="vertical-align: top; vertical-align: bottom"> </td>
<td style="vertical-align: bottom; vertical-align: bottom"> </td>
<td colspan="2" style="vertical-align: top; vertical-align: bottom">
<div style="text-align: right; font: 10pt Times New Roman, Times, serif">USA</div>
<div style="text-align: right; font: 10pt Times New Roman, Times, serif">2015</div>
<div style="text-align: right; font: 10pt Times New Roman, Times, serif">$</div>
</td>
<td nowrap="nowrap" style="text-align: left; vertical-align: bottom; vertical-align: bottom"> </td>
<td style="vertical-align: bottom; vertical-align: bottom"> </td>
<td colspan="2" style="vertical-align: top; vertical-align: bottom">
<div style="text-align: right; font: 10pt Times New Roman, Times, serif">Total</div>
<div style="text-align: right; font: 10pt Times New Roman, Times, serif">2015</div>
<div style="text-align: right; font: 10pt Times New Roman, Times, serif">$</div>
</td>
<td nowrap="nowrap" style="text-align: left; vertical-align: bottom; vertical-align: bottom"> </td>
</tr>
<tr>
<td style="vertical-align: top; vertical-align: bottom">
<div style="text-align: left; font: 10pt Times New Roman, Times, serif">Deferred tax assets</div>
</td>
<td style="vertical-align: bottom; vertical-align: bottom"> </td>
<td colspan="2" style="vertical-align: top; vertical-align: bottom"> </td>
<td nowrap="nowrap" style="text-align: left; vertical-align: bottom; vertical-align: bottom"> </td>
<td style="vertical-align: bottom; vertical-align: bottom"> </td>
<td colspan="2" style="vertical-align: top; vertical-align: bottom"> </td>
<td nowrap="nowrap" style="text-align: left; vertical-align: bottom; vertical-align: bottom"> </td>
</tr>
<tr>
<td style="vertical-align: top; vertical-align: bottom"> </td>
<td style="vertical-align: bottom; vertical-align: bottom"> </td>
<td colspan="2" style="vertical-align: top; vertical-align: bottom"> </td>
<td nowrap="nowrap" style="text-align: left; vertical-align: bottom; vertical-align: bottom"> </td>
<td style="vertical-align: bottom; vertical-align: bottom"> </td>
<td colspan="2" style="vertical-align: top; vertical-align: bottom"> </td>
<td nowrap="nowrap" style="text-align: left; vertical-align: bottom; vertical-align: bottom"> </td>
</tr>
<tr>
<td style="vertical-align: top; vertical-align: bottom"> </td>
<td style="vertical-align: bottom; vertical-align: bottom"> </td>
<td colspan="2" style="vertical-align: top; vertical-align: bottom"> </td>
<td nowrap="nowrap" style="text-align: left; vertical-align: bottom; vertical-align: bottom"> </td>
<td style="vertical-align: bottom; vertical-align: bottom"> </td>
<td colspan="2" style="vertical-align: top; vertical-align: bottom"> </td>
<td nowrap="nowrap" style="text-align: left; vertical-align: bottom; vertical-align: bottom"> </td>
</tr>
<tr>
<td style="width: 72%; vertical-align: top; vertical-align: bottom">
<div style="text-align: left; font: 10pt Times New Roman, Times, serif">Net operating loss carry-forward</div>
</td>
<td style="width: 1%; vertical-align: bottom; vertical-align: bottom"> </td>
<td style="text-align: left; width: 1%; vertical-align: bottom; vertical-align: bottom"> </td>
<td style="text-align: right; width: 11%; vertical-align: bottom; vertical-align: bottom">
<div style="font: 10pt Times New Roman, Times, serif">827,643</div>
</td>
<td nowrap="nowrap" style="text-align: left; width: 1%; vertical-align: bottom; vertical-align: bottom"> </td>
<td style="width: 1%; vertical-align: bottom; vertical-align: bottom"> </td>
<td style="text-align: left; width: 1%; vertical-align: bottom; vertical-align: bottom"> </td>
<td style="text-align: right; width: 11%; vertical-align: bottom; vertical-align: bottom">
<div style="font: 10pt Times New Roman, Times, serif">827,643</div>
</td>
<td nowrap="nowrap" style="text-align: left; width: 1%; vertical-align: bottom; vertical-align: bottom"> </td>
</tr>
<tr>
<td style="width: 72%; vertical-align: top; vertical-align: bottom"> </td>
<td style="width: 1%; vertical-align: bottom; vertical-align: bottom"> </td>
<td style="text-align: left; width: 1%; vertical-align: bottom; vertical-align: bottom"> </td>
<td style="text-align: right; width: 11%; vertical-align: bottom; vertical-align: bottom"> </td>
<td nowrap="nowrap" style="text-align: left; width: 1%; vertical-align: bottom; vertical-align: bottom"> </td>
<td style="width: 1%; vertical-align: bottom; vertical-align: bottom"> </td>
<td style="text-align: left; width: 1%; vertical-align: bottom; vertical-align: bottom"> </td>
<td style="text-align: right; width: 11%; vertical-align: bottom; vertical-align: bottom"> </td>
<td nowrap="nowrap" style="text-align: left; width: 1%; vertical-align: bottom; vertical-align: bottom"> </td>
</tr>
<tr>
<td style="padding-bottom: 2px; width: 72%; vertical-align: top; vertical-align: bottom">
<div style="text-align: left; font: 10pt Times New Roman, Times, serif">Less valuation allowance</div>
</td>
<td style="padding-bottom: 2px; width: 1%; vertical-align: bottom; vertical-align: bottom"> </td>
<td style="border-bottom: #000000 2px solid; text-align: left; width: 1%; vertical-align: bottom; vertical-align: bottom"> </td>
<td style="border-bottom: #000000 2px solid; text-align: right; width: 11%; vertical-align: bottom; vertical-align: bottom">
<div style="font: 10pt Times New Roman, Times, serif">(827,643</div>
</td>
<td nowrap="nowrap" style="border-bottom: #000000 2px solid; text-align: left; width: 1%; vertical-align: bottom; vertical-align: bottom">
<div style="font: 10pt Times New Roman, Times, serif">)</div>
</td>
<td style="border-bottom: #000000 2px solid; width: 1%; vertical-align: bottom; vertical-align: bottom"> </td>
<td style="border-bottom: #000000 2px solid; text-align: left; width: 1%; vertical-align: bottom; vertical-align: bottom"> </td>
<td style="border-bottom: #000000 2px solid; text-align: right; width: 11%; vertical-align: bottom; vertical-align: bottom">
<div style="font: 10pt Times New Roman, Times, serif">(827,643</div>
</td>
<td nowrap="nowrap" style="border-bottom: #000000 2px solid; text-align: left; width: 1%; vertical-align: bottom; vertical-align: bottom">
<div style="font: 10pt Times New Roman, Times, serif">)</div>
</td>
</tr>
<tr>
<td style="width: 72%; vertical-align: top; vertical-align: bottom"> </td>
<td style="width: 1%; vertical-align: bottom; vertical-align: bottom"> </td>
<td style="text-align: left; width: 1%; vertical-align: bottom; vertical-align: bottom"> </td>
<td style="text-align: right; width: 11%; vertical-align: bottom; vertical-align: bottom"> </td>
<td nowrap="nowrap" style="text-align: left; width: 1%; vertical-align: bottom; vertical-align: bottom"> </td>
<td style="width: 1%; vertical-align: bottom; vertical-align: bottom"> </td>
<td style="text-align: left; width: 1%; vertical-align: bottom; vertical-align: bottom"> </td>
<td style="text-align: right; width: 11%; vertical-align: bottom; vertical-align: bottom"> </td>
<td nowrap="nowrap" style="text-align: left; width: 1%; vertical-align: bottom; vertical-align: bottom"> </td>
</tr>
<tr>
<td style="padding-bottom: 2px; width: 72%; vertical-align: top; vertical-align: bottom">
<div style="text-align: left; font: 10pt Times New Roman, Times, serif">Net deferred taxes</div>
</td>
<td style="padding-bottom: 2px; width: 1%; vertical-align: bottom; vertical-align: bottom"> </td>
<td style="border-bottom: #000000 2px solid; text-align: left; width: 1%; vertical-align: bottom; vertical-align: bottom"> </td>
<td style="border-bottom: #000000 2px solid; text-align: right; width: 11%; vertical-align: bottom; vertical-align: bottom">
<div style="font: 10pt Times New Roman, Times, serif">-</div>
</td>
<td nowrap="nowrap" style="border-bottom: #000000 2px solid; text-align: left; width: 1%; vertical-align: bottom; vertical-align: bottom"> </td>
<td style="border-bottom: #000000 2px solid; width: 1%; vertical-align: bottom; vertical-align: bottom"> </td>
<td style="border-bottom: #000000 2px solid; text-align: left; width: 1%; vertical-align: bottom; vertical-align: bottom"> </td>
<td style="border-bottom: #000000 2px solid; text-align: right; width: 11%; vertical-align: bottom; vertical-align: bottom">
<div style="font: 10pt Times New Roman, Times, serif">-</div>
</td>
<td nowrap="nowrap" style="border-bottom: #000000 2px solid; text-align: left; width: 1%; vertical-align: bottom; vertical-align: bottom"> </td>
</tr>
</table>
</div>
<div style="text-align: left"> </div>
<div style="text-align: justify; text-indent: 36pt; font: 10pt Times New Roman, Times, serif; margin-bottom: 10pt; color: #000000">The Company has available net operating loss carry forwards as of October 31, 2015, which are subject to limitations, aggregating approximately $2,285,000 which would expire in years 2028 through 2034.</div>
<div style="text-align: justify; text-indent: 36pt; font: 10pt Times New Roman, Times, serif; margin-bottom: 10pt; color: #000000">The Company’s tax returns for all years since fiscal 2012 remain open to examination by the respective tax authorities.  There are currently no tax examinations in progress.</div>
<div style="text-align: center"><table id="z243cea740b9747849d2bf4a0d0009c3c" class="DSPFListTable" cellspacing="0" cellpadding="0" style="width: 100%; font: 10pt Times New Roman, Times, serif"><tr><td style="width: 36pt; vertical-align: top"><div style="text-align: left; font: bold 10pt Times New Roman, Times, serif">(6)</div>
</td>
<td style="width: auto; vertical-align: top">
<div style="text-align: left; font: bold 10pt Times New Roman, Times, serif">STOCKHOLDERS’ EQUITY</div>
</td>
</tr>
</table>
</div>
<div style="text-align: left"> </div>
<div style="text-align: justify; text-indent: 36pt; font: 10pt Times New Roman, Times, serif; margin-bottom: 10pt; color: #000000">In September 2008, 96,000,000 shares of common stock were issued to the Company’s founder raising $9,000.</div>
<div style="text-align: justify; text-indent: 36pt; font: 10pt Times New Roman, Times, serif; margin-bottom: 10pt; color: #000000">In March 2009, the Company raised $12,000 in a registered public offering of 9,600,000 shares of common stock share pursuant to a prospectus dated January 30, 2009.</div>
<div style="text-align: justify; text-indent: 36pt; font: 10pt Times New Roman, Times, serif; margin-bottom: 10pt; color: #000000">On July 31, 2015 the Company issued 30,000,000 shares of common stock to AXIS in satisfaction of a debt of $5,057,776.</div>
<div style="text-align: justify; text-indent: 36pt; font: 10pt Times New Roman, Times, serif; margin-bottom: 10pt; color: #000000">On April 7, 2016, the Company raised $38,329 in a private placement through the offer of 250,000 shares of common stock.</div>
<div style="text-align: center"><table id="z7369c67cca41419493cd86deb6ca91e4" class="DSPFListTable" cellspacing="0" cellpadding="0" style="width: 100%; font: 10pt Times New Roman, Times, serif"><tr><td style="width: 36pt; vertical-align: top"><div style="text-align: left; font: bold 10pt Times New Roman, Times, serif">(10)</div>
</td>
<td style="width: auto; vertical-align: top">
<div style="text-align: left; font: bold 10pt Times New Roman, Times, serif">SUBSEQUENT EVENTS</div>
</td>
</tr>
</table>
</div>
<div style="text-align: left"> </div>
<div style="text-align: justify; text-indent: 36pt; font: 10pt Times New Roman, Times, serif; margin-bottom: 10pt; color: #000000">The Company has evaluated events and transactions after the balance sheet date and through the date the consolidated financial statements were issued, and believes that all relevant disclosures have been included herein and there are no other events which require recognition or disclosure in the accompanying interim consolidated financial statements.</div>
<div style="text-align: left; text-indent: 36pt; font: 10pt Times New Roman, Times, serif; margin-bottom: 10pt">On July 19, 2017, the Company entered into a Term Sheet with Lior Wayn, Erez Glazer and Dr Guy Shalom, (collectively, the ‘’Sellers”)  for the acquisition of all of the issued shares of a medical technology business. The Company has a 120 day period to conduct due diligence and negotiate a formal share sale agreement.</div>
<div style="text-align: justify; text-indent: 36pt; font: 10pt Times New Roman, Times, serif">The purchase price is up to USD$7,500,000 which is to be satisfied as follows:</div>
<div style="text-align: center"><br />
</div>
<div style="text-align: center">
<table id="z57cff6e86a114109bb8034acbb0412e5" class="DSPFListTable" cellspacing="0" cellpadding="0" style="width: 100%; font: 10pt Times New Roman, Times, serif">
<tr>
<td style="width: 72pt; vertical-align: top">
<div style="text-align: left; font: 10pt Times New Roman, Times, serif; margin-left: 54pt">f)</div>
</td>
<td style="width: auto; vertical-align: top">
<div style="text-align: justify; font: 10pt Times New Roman, Times, serif">The sum of USD$100,000 payable to the Sellers for due diligence expenses, 30 business days from the execution of the Term Sheet;</div>
</td>
</tr>
</table>
</div>
<div style="text-align: center"><br />
</div>
<div style="text-align: center">
<table id="z1cbb6430a0e4473e9945f3f98731dbf2" class="DSPFListTable" cellspacing="0" cellpadding="0" style="width: 100%; font: 10pt Times New Roman, Times, serif">
<tr>
<td style="width: 72pt; vertical-align: top">
<div style="text-align: left; font: 10pt Times New Roman, Times, serif; margin-left: 54pt">g)</div>
</td>
<td style="width: auto; vertical-align: top">
<div style="text-align: justify; font: 10pt Times New Roman, Times, serif"> A further USD$100,000 each month after the date in a) above for due diligence expenses, for 3 months,  payable to the Sellers for working capital purposes;</div>
</td>
</tr>
</table>
</div>
<div style="text-align: center"><br />
</div>
<div style="text-align: center">
<table id="zecdd3a3b859049639e8435eafe0de5b0" class="DSPFListTable" cellspacing="0" cellpadding="0" style="width: 100%; font: 10pt Times New Roman, Times, serif">
<tr>
<td style="width: 72pt; vertical-align: top">
<div style="text-align: left; font: 10pt Times New Roman, Times, serif; margin-left: 54pt">h)</div>
</td>
<td style="width: auto; vertical-align: top">
<div style="text-align: justify; font: 10pt Times New Roman, Times, serif">An issue of fully paid ordinary shares of common stock of the Company to the value of USD$2,500,000 (less any payments made to the Sellers under (a) and (b) above) to the Sellers at an issue price of USD$0.22 per share of common stock (Consideration Shares);</div>
</td>
</tr>
</table>
</div>
<div style="text-align: center"><br />
</div>
<div style="text-align: center">
<table id="zd7a06baf55c94359adf82c2647605a2a" class="DSPFListTable" cellspacing="0" cellpadding="0" style="width: 100%; font: 10pt Times New Roman, Times, serif">
<tr>
<td style="width: 72pt; vertical-align: top">
<div style="text-align: left; font: 10pt Times New Roman, Times, serif; margin-left: 54pt">i)</div>
</td>
<td style="width: auto; vertical-align: top">
<div style="text-align: justify; font: 10pt Times New Roman, Times, serif">The issue to the Sellers of shares of common stock to the equivalent to USD$2,500,000 at the issue price of USD$0.22, subject to the Sellers achieving sales revenue of USD$100,000 within twelve months after the first anniversary of Completion; and</div>
</td>
</tr>
</table>
</div>
<div style="text-align: center"><br />
</div>
<div style="text-align: center">
<table id="z30e6e795a87146d48aa627a0c2cca9db" class="DSPFListTable" cellspacing="0" cellpadding="0" style="width: 100%; font: 10pt Times New Roman, Times, serif">
<tr>
<td style="width: 72pt; vertical-align: top">
<div style="text-align: left; font: 10pt Times New Roman, Times, serif; margin-left: 54pt">j)</div>
</td>
<td style="width: auto; vertical-align: top">
<div style="text-align: justify; font: 10pt Times New Roman, Times, serif">The issue to the Sellers of shares of common stock to the equivalent to USD$2,500,000 at the issue price of USD$0.22, subject to the Sellers achieving sales revenue of USD$1,000,000 within twelve months after the first anniversary of Completion.</div>
</td>
</tr>
</table>
</div>
<div id="DSPFPageBreakArea" style="margin-top: 10pt; margin-bottom: 10pt; clear: both">
</div>
<div style="text-align: left; text-indent: 36pt; font: 10pt Times New Roman, Times, serif; color: #000000">If the Transaction is terminated or is in the reasonable opinion of the Company unable to proceed at any point, the Vendors and the Sellers have agreed to convert any monies paid to the Sellers under (a) and (b) above into convertible securities in the Sellers.</div>
<div style="text-align: center"><br />
</div>
<div style="text-align: left; text-indent: 36pt; font: 10pt Times New Roman, Times, serif; color: #000000">As part of the agreement and as a condition to completion, the Company will raise USD$2,500,000.</div>
<div style="text-align: center"><br />
</div>
<div style="text-align: left; text-indent: 36pt; font: 10pt Times New Roman, Times, serif; color: #000000">Pending completion, the Sellers are required to carry on business in the ordinary course.</div>
<div style="text-align: center"><br />
</div>
<div style="text-align: justify; text-indent: 36pt; font: 10pt Times New Roman, Times, serif; margin-bottom: 10pt; color: #000000">In July 2017, the Company raised $38,329 through the private placement of 250,000 shares of common stock.</div>
<div style="text-align: justify; text-indent: 36pt; font: 10pt Times New Roman, Times, serif; margin-bottom: 10pt; color: #000000">The Company is required to file tax returns in the United States and a summary of the deferred tax asset at July 31, 2016 is as follows:</div>
<div style="text-align: center">
<table id="zd482b361cebc47b9942488b23677f616" cellspacing="0" cellpadding="0" style="width: 100%; font: 10pt Times New Roman, Times, serif">
<tr>
<td style="vertical-align: bottom; vertical-align: top"> </td>
<td style="vertical-align: bottom; vertical-align: bottom"> </td>
<td colspan="2" style="vertical-align: bottom; vertical-align: top">
<div style="text-align: right; font: 10pt Times New Roman, Times, serif">USA</div>
<div style="text-align: right; font: 10pt Times New Roman, Times, serif">2015</div>
<div style="text-align: right; font: 10pt Times New Roman, Times, serif">$</div>
</td>
<td nowrap="nowrap" style="vertical-align: bottom; text-align: left; vertical-align: bottom"> </td>
<td style="vertical-align: bottom; vertical-align: bottom"> </td>
<td colspan="2" style="vertical-align: bottom; vertical-align: top">
<div style="text-align: right; font: 10pt Times New Roman, Times, serif">Total</div>
<div style="text-align: right; font: 10pt Times New Roman, Times, serif">2015</div>
<div style="text-align: right; font: 10pt Times New Roman, Times, serif">$</div>
</td>
<td nowrap="nowrap" style="vertical-align: bottom; text-align: left; vertical-align: bottom"> </td>
</tr>
<tr>
<td style="vertical-align: bottom; vertical-align: top">
<div style="text-align: left; font: 10pt Times New Roman, Times, serif">Deferred tax assets</div>
</td>
<td style="vertical-align: bottom; vertical-align: bottom"> </td>
<td colspan="2" style="vertical-align: bottom; vertical-align: top"> </td>
<td nowrap="nowrap" style="vertical-align: bottom; text-align: left; vertical-align: bottom"> </td>
<td style="vertical-align: bottom; vertical-align: bottom"> </td>
<td colspan="2" style="vertical-align: bottom; vertical-align: top"> </td>
<td nowrap="nowrap" style="vertical-align: bottom; text-align: left; vertical-align: bottom"> </td>
</tr>
<tr>
<td style="vertical-align: bottom; vertical-align: top"> </td>
<td style="vertical-align: bottom; vertical-align: bottom"> </td>
<td colspan="2" style="vertical-align: bottom; vertical-align: top"> </td>
<td nowrap="nowrap" style="vertical-align: bottom; text-align: left; vertical-align: bottom"> </td>
<td style="vertical-align: bottom; vertical-align: bottom"> </td>
<td colspan="2" style="vertical-align: bottom; vertical-align: top"> </td>
<td nowrap="nowrap" style="vertical-align: bottom; text-align: left; vertical-align: bottom"> </td>
</tr>
<tr>
<td style="vertical-align: bottom; vertical-align: top"> </td>
<td style="vertical-align: bottom; vertical-align: bottom"> </td>
<td colspan="2" style="vertical-align: bottom; vertical-align: top"> </td>
<td nowrap="nowrap" style="vertical-align: bottom; text-align: left; vertical-align: bottom"> </td>
<td style="vertical-align: bottom; vertical-align: bottom"> </td>
<td colspan="2" style="vertical-align: bottom; vertical-align: top"> </td>
<td nowrap="nowrap" style="vertical-align: bottom; text-align: left; vertical-align: bottom"> </td>
</tr>
<tr>
<td style="vertical-align: bottom; width: 72%; vertical-align: top">
<div style="text-align: left; font: 10pt Times New Roman, Times, serif">Net operating loss carry-forward</div>
</td>
<td style="vertical-align: bottom; width: 1%; vertical-align: bottom"> </td>
<td style="vertical-align: bottom; text-align: left; width: 1%; vertical-align: bottom"> </td>
<td style="vertical-align: bottom; text-align: right; width: 11%; vertical-align: bottom">
<div style="font: 10pt Times New Roman, Times, serif">827,643</div>
</td>
<td nowrap="nowrap" style="vertical-align: bottom; text-align: left; width: 1%; vertical-align: bottom"> </td>
<td style="vertical-align: bottom; width: 1%; vertical-align: bottom"> </td>
<td style="vertical-align: bottom; text-align: left; width: 1%; vertical-align: bottom"> </td>
<td style="vertical-align: bottom; text-align: right; width: 11%; vertical-align: bottom">
<div style="font: 10pt Times New Roman, Times, serif">827,643</div>
</td>
<td nowrap="nowrap" style="vertical-align: bottom; text-align: left; width: 1%; vertical-align: bottom"> </td>
</tr>
<tr>
<td style="vertical-align: bottom; width: 72%; vertical-align: top"> </td>
<td style="vertical-align: bottom; width: 1%; vertical-align: bottom"> </td>
<td style="vertical-align: bottom; text-align: left; width: 1%; vertical-align: bottom"> </td>
<td style="vertical-align: bottom; text-align: right; width: 11%; vertical-align: bottom"> </td>
<td nowrap="nowrap" style="vertical-align: bottom; text-align: left; width: 1%; vertical-align: bottom"> </td>
<td style="vertical-align: bottom; width: 1%; vertical-align: bottom"> </td>
<td style="vertical-align: bottom; text-align: left; width: 1%; vertical-align: bottom"> </td>
<td style="vertical-align: bottom; text-align: right; width: 11%; vertical-align: bottom"> </td>
<td nowrap="nowrap" style="vertical-align: bottom; text-align: left; width: 1%; vertical-align: bottom"> </td>
</tr>
<tr>
<td style="vertical-align: bottom; padding-bottom: 2px; width: 72%; vertical-align: top">
<div style="text-align: left; font: 10pt Times New Roman, Times, serif">Less valuation allowance</div>
</td>
<td style="vertical-align: bottom; padding-bottom: 2px; width: 1%; vertical-align: bottom"> </td>
<td style="vertical-align: bottom; border-bottom: #000000 2px solid; text-align: left; width: 1%; vertical-align: bottom"> </td>
<td style="vertical-align: bottom; border-bottom: #000000 2px solid; text-align: right; width: 11%; vertical-align: bottom">
<div style="font: 10pt Times New Roman, Times, serif">(827,643</div>
</td>
<td nowrap="nowrap" style="vertical-align: bottom; border-bottom: #000000 2px solid; text-align: left; width: 1%; vertical-align: bottom">
<div style="font: 10pt Times New Roman, Times, serif">)</div>
</td>
<td style="vertical-align: bottom; border-bottom: #000000 2px solid; width: 1%; vertical-align: bottom"> </td>
<td style="vertical-align: bottom; border-bottom: #000000 2px solid; text-align: left; width: 1%; vertical-align: bottom"> </td>
<td style="vertical-align: bottom; border-bottom: #000000 2px solid; text-align: right; width: 11%; vertical-align: bottom">
<div style="font: 10pt Times New Roman, Times, serif">(827,643</div>
</td>
<td nowrap="nowrap" style="vertical-align: bottom; border-bottom: #000000 2px solid; text-align: left; width: 1%; vertical-align: bottom">
<div style="font: 10pt Times New Roman, Times, serif">)</div>
</td>
</tr>
<tr>
<td style="vertical-align: bottom; width: 72%; vertical-align: top"> </td>
<td style="vertical-align: bottom; width: 1%; vertical-align: bottom"> </td>
<td style="vertical-align: bottom; text-align: left; width: 1%; vertical-align: bottom"> </td>
<td style="vertical-align: bottom; text-align: right; width: 11%; vertical-align: bottom"> </td>
<td nowrap="nowrap" style="vertical-align: bottom; text-align: left; width: 1%; vertical-align: bottom"> </td>
<td style="vertical-align: bottom; width: 1%; vertical-align: bottom"> </td>
<td style="vertical-align: bottom; text-align: left; width: 1%; vertical-align: bottom"> </td>
<td style="vertical-align: bottom; text-align: right; width: 11%; vertical-align: bottom"> </td>
<td nowrap="nowrap" style="vertical-align: bottom; text-align: left; width: 1%; vertical-align: bottom"> </td>
</tr>
<tr>
<td style="vertical-align: bottom; padding-bottom: 2px; width: 72%; vertical-align: top">
<div style="text-align: left; font: 10pt Times New Roman, Times, serif">Net deferred taxes</div>
</td>
<td style="vertical-align: bottom; padding-bottom: 2px; width: 1%; vertical-align: bottom"> </td>
<td style="vertical-align: bottom; border-bottom: #000000 2px solid; text-align: left; width: 1%; vertical-align: bottom"> </td>
<td style="vertical-align: bottom; border-bottom: #000000 2px solid; text-align: right; width: 11%; vertical-align: bottom">
<div style="font: 10pt Times New Roman, Times, serif">-</div>
</td>
<td nowrap="nowrap" style="vertical-align: bottom; border-bottom: #000000 2px solid; text-align: left; width: 1%; vertical-align: bottom"> </td>
<td style="vertical-align: bottom; border-bottom: #000000 2px solid; width: 1%; vertical-align: bottom"> </td>
<td style="vertical-align: bottom; border-bottom: #000000 2px solid; text-align: left; width: 1%; vertical-align: bottom"> </td>
<td style="vertical-align: bottom; border-bottom: #000000 2px solid; text-align: right; width: 11%; vertical-align: bottom">
<div style="font: 10pt Times New Roman, Times, serif">-</div>
</td>
<td nowrap="nowrap" style="vertical-align: bottom; border-bottom: #000000 2px solid; text-align: left; width: 1%; vertical-align: bottom"> </td>
</tr>
</table></div>
<div style="text-align: center"><table id="z7f69509ff7244fcb9dbc3b4ca18515bb" class="DSPFListTable" cellspacing="0" cellpadding="0" style="width: 100%; font: 10pt Times New Roman, Times, serif"><tr><td style="width: 36pt; vertical-align: top"><div style="text-align: left; font: bold 10pt Times New Roman, Times, serif">(7)</div>
</td>
<td style="width: auto; vertical-align: top">
<div style="text-align: left; font: bold 10pt Times New Roman, Times, serif">FAIR VALUE OF FINANCIAL INSTRUMENTS</div>
</td>
</tr>
</table>
</div>
<div style="text-align: left"> </div>
<div style="text-align: justify; text-indent: 36pt; font: 10pt Times New Roman, Times, serif; margin-bottom: 10pt; color: #000000">The Company’s financial instruments consist of cash, receivables, accounts payable, accrued expenses and advances from affiliates. The carrying amounts of cash, receivables, accounts payables and accrued expenses approximates their fair values because of the short term maturities of those instruments.  The fair value of the advances from affiliate is not determinable as it is due to an affiliated entity, no market exists for similar instruments and settlement date is uncertain.</div>
<div style="text-align: center"><table id="z337cea4008374b8a8ba45024408f5673" class="DSPFListTable" cellspacing="0" cellpadding="0" style="width: 100%; font: 10pt Times New Roman, Times, serif"><tr><td style="width: 36pt; vertical-align: top"><div style="text-align: left; font: bold 10pt Times New Roman, Times, serif">(8)</div>
</td>
<td style="width: auto; vertical-align: top">
<div style="text-align: left; font: bold 10pt Times New Roman, Times, serif">NET INCOME (LOSS) PER SHARE</div>
</td>
</tr>
</table>
</div>
<div style="text-align: left"> </div>
<div style="text-align: justify; text-indent: 36pt; font: 10pt Times New Roman, Times, serif; margin-bottom: 10pt; color: #000000">Basic income (loss) per share is computed by dividing net profit (loss) available to common stockholders by the weighted average number of common shares outstanding during the period.</div>
<div style="text-align: left; font: 10pt Times New Roman, Times, serif; color: #000000"><table id="zaaf2a9a6a7384d0c98e221cec057a323" class="DSPFListTable" cellspacing="0" cellpadding="0" style="width: 100%; font: 10pt Times New Roman, Times, serif"><tr><td style="width: 36pt; vertical-align: top"><div style="text-align: left; font: bold 10pt Times New Roman, Times, serif">(9)</div>
</td>
<td style="width: auto; vertical-align: top">
<div style="text-align: left; font: bold 10pt Times New Roman, Times, serif">CASH</div>
</td>
</tr>
</table>
</div>
<div style="text-align: left; font: 10pt Times New Roman, Times, serif; color: #000000"> </div>
<div style="text-align: justify; text-indent: 36pt; font: 10pt Times New Roman, Times, serif; margin-bottom: 10pt; color: #000000">The Company maintains cash deposits with financial institutions in Australia and in Laos (USD).  Cash deposits maintained in Australian dollars are translated into US dollars at the period end exchange rate with the related adjustment recognized in statements of operations.</div>
66646
57809
-38300
-93491
-10350
-45933
38300
93491
10350
45933
248
114
105
5577
43737
750
22610
32475
49640
9600
23218
0.00
0.00
0.00
0.00
-92994
1181414
-9906
591987
-54694
1208259
444
580111
33229
-89769
71529
-63887
-963
437
197
3073
1076
240
-1997
464
1470
-33453
86302
5057776
135662000
105710000
135850000
105993000
-71782
86302
827643
827643
827643
827643